Education
About Us
Working with TipRanks
Follow Us
Veeva Systems (VEEV)
NYSE:VEEV
VEEV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$170.25 - $258.93
Previous CloseN/A
Volume260.89K
Average Volume (3M)1.33M
Market Cap
$38.11B
Enterprise Value$33.57B
Total Cash (Recent Filing)$257.14M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)54.1
Beta1.17
Next Earnings
May 29, 2025EPS Estimate
1.74Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.33
Shares Outstanding162,696,040
10 Day Avg. Volume926,694
30 Day Avg. Volume1,325,296
Financial Highlights & Ratios
PEG Ratio1.56
Price to Book (P/B)N/A
Price to Sales (P/S)18.98
Price to Cash Flow (P/CF)58.60
P/FCF Ratio60.10
Enterprise Value/Market Cap0.88
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit16.40
Enterprise Value/Ebitda47.22
Forecast
1Y Price Target
$265.09Price Target Upside14.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering23
---
Bulls Say, Bears Say
Bulls Say
Customer GrowthVeeva expanded with a major top 20 customer that is going 'all in' with Veeva's R&D platform, indicating strong customer trust and future growth potential.
Financial PerformanceVeeva Systems Inc provided initial FY26 EPS guidance that is well above Street's current view, driven by revenue guidance that also exceeds expectations.
Product DevelopmentVeeva's AI strategy includes offering new AI solutions for free within its existing products, which enhances value for customers and could strengthen market position.
Bears Say
Industry DynamicsThe projected P/E has been trimmed due to a slightly more mixed set of industry dynamics, including CRO pressure and NIH funding risk.
Investment ConcernsSome investors may have concerns about material incremental investments over the next several years.
Market ValuationMuch of the near-term upside is believed to be priced into the shares, supporting a Neutral rating on valuation.
---
Ownership Overview
9.94% Insiders
27.68% Mutual Funds
24.94% Other Institutional Investors
22.06% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VEEV FAQ
What was Veeva Systems’s price range in the past 12 months?
Veeva Systems lowest stock price was $170.25 and its highest was $258.93 in the past 12 months.
What is Veeva Systems’s market cap?
Veeva Systems’s market cap is $38.11B.
When is Veeva Systems’s upcoming earnings report date?
Veeva Systems’s upcoming earnings report date is May 29, 2025 which is in 58 days.
How were Veeva Systems’s earnings last quarter?
Veeva Systems released its earnings results on Mar 05, 2025. The company reported $1.74 earnings per share for the quarter, beating the consensus estimate of $1.599 by $0.141.
Is Veeva Systems overvalued?
According to Wall Street analysts Veeva Systems’s price is currently Undervalued.
Does Veeva Systems pay dividends?
Veeva Systems does not currently pay dividends.
What is Veeva Systems’s EPS estimate?
Veeva Systems’s EPS estimate is 1.74.
How many shares outstanding does Veeva Systems have?
Veeva Systems has 162,696,040 shares outstanding.
What happened to Veeva Systems’s price movement after its last earnings report?
Veeva Systems reported an EPS of $1.74 in its last earnings report, beating expectations of $1.599. Following the earnings report the stock price went up 7.366%.
Which hedge fund is a major shareholder of Veeva Systems?
Currently, no hedge funds are holding shares in VEEV
---
Veeva Systems Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$265.09 (14.45% Upside)
$265.09 (14.45% Upside)
Blogger Sentiment
Bullish
VEEV Sentiment 90%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 241.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.02%
12-Months-Change
Fundamentals
Return on Equity
13.63%
Trailing 12-Months
Asset Growth
24.17%
Trailing 12-Months
Company Description
Veeva Systems
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
---
VEEV Company Deck
---
VEEV Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call for Veeva Systems highlighted a strong finish to the fiscal year with robust financial performance and strategic wins, particularly in the clinical space. Significant advancements in AI and data cloud offerings position the company well for future growth. However, the guidance reflects slight deceleration in subscription growth, and there are potential external risks due to policy changes that could affect future performance. Overall, the positive momentum and strategic achievements outweigh the challenges noted.Read More>---
VEEV Revenue Breakdown
58.18% North America
27.79% Europe
11.35% APAC
2.68% Middle East, Africa, and Latin America
---
VEEV Stock 12 Month Forecast
Average Price Target
$265.09
▲(14.45% Upside)
Technical Analysis
Alnylam Pharma
―
Edwards Lifesciences
―
IQVIA Holdings
―
Argenx Se
―
GE Healthcare Technologies Inc
―
Best Analysts Covering VEEV
1 Year
1 Year Success Rate
16/21 ratings generated profit
1 Year Average Return
+11.13%
reiterated a buy rating 4 days ago
Copying Saket Kalia's trades and holding each position for 1 Year would result in 76.19% of your transactions generating a profit, with an average return of +11.13% per trade.
---